Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 2024 Oct 24;131(10):1719. doi: 10.1038/s41416-024-02862-w

Author Correction: CDK9 inhibition constrains multiple oncogenic transcriptional and epigenetic pathways in prostate cancer

Razia Rahman 1,#, Muhammed H Rahaman 2,#, Adrienne R Hanson 1, Nicholas Choo 3, Jianling Xie 1, Scott L Townley 1, Raj Shrestha 1,4, Ramin Hassankhani 2, Saiful Islam 2, Susanne Ramm 5,6, Kaylene J Simpson 5,6,7, Gail P Risbridger 3,6,8,9,10, Giles Best 1, Margaret M Centenera 11,12, Steven P Balk 13, Ganessan Kichenadasse 1,14, Renea A Taylor 6,8,9,10,15, Lisa M Butler 11,12, Wayne D Tilley 12,16, Simon J Conn 1, Mitchell G Lawrence 3,6,8,9,10, Shudong Wang 2, Luke A Selth 1,4,12,
PMCID: PMC11555365  PMID: 39448861

Correction to: British Journal of Cancer (2024) 131:1092-1105; 10.1038/s41416-024-02810-8, published online 08 August 2024

In this article the title was incorrectly given as “CDK9 inhibition inhibits multiple oncogenic transcriptional and epigenetic pathways in prostate cancer” but should have been “CDK9 inhibition constrains multiple oncogenic transcriptional and epigenetic pathways in prostate cancer”.

The original article has been corrected.

Footnotes

The original article can be found online at 10.1038/s41416-024-02810-8.

These authors contributed equally: Razia Rahman, Muhammed H. Rahaman.

These authors jointly supervised this work: Shudong Wang and Luke A. Selth.


Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES